3 services
Pricing and market access
We stay with you as clinical and economic value is turned into durable market-access decisions
A product’s clinical value does not fully reach patients until it becomes a reimbursement approval. We translate clinical and economic evidence into the format institutions expect.
3 services
The regulator’s language
Our team is led by specialists who served for many years on the SGK Medical-Economic Evaluation Commission and TITCK scientific commissions, so we know the regulatory requirements first-hand.
- 03.1
Market access & reimbursement dossiers
SUT filings, dossier preparation and management of the reimbursement-commission process
- 03.2
Pharmacoeconomic analysis & modeling
Cost-effectiveness, budget-impact analysis and decision-analytic modeling
- 03.3
Pharmaceutical pricing
Initial price application, reference-price changes and pricing strategy
Let’s talk about your access strategy
Write to us with your product’s indication and target price range and we will map out a route.
Services
- 01
Product research-development and regulatory affairs
From concept to dossier: scientific planning and a submission that meets the rules
- 02
Safety and toxicological assessment
Toxicological assessment, exposure limits, product safety and impurity evaluation
- 04
Mentor Ar-Ge Academy and MentorSuperIntelligence